Glioblastoma (GBM) stem-like cells (GSCs) represent the most undifferentiated state of malignant cells with distinct biological characteristics. The fraction of these cells within a glial brain tumor, ranging from 2-30%, is correlating with the increasingWHOstageandpoorprognosisofpatients'survival.GSCsrepresenttheleastvulnerable,thusmostpreferentialtarget cellpopulationtobeexposedtovarioustherapeuticmodalities,althoughtheunderlyingmechanismsofthisresistancearenotyet fully understood. For the development of GSC-targeting therapies, further in depth studies are needed using enrichedand stable GSCcellpopulations.Here,wediscussthecurrentapproachesofGSCisolationandvalidationbasedonexpressionofstemness and oncogenic markers as well as on functional assays. The enrichment of GSC phenotypes in established cell lines and/or primary tumor cultures, achieved by different strategies, is reviewed, providing a comprehensive comparison of selected studies and contemplating the characterization of the plethora of variants of reported GBM population exhibiting the GSC phenotype.
No takes yet. Share an insight, caveat, or question.
Molina et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: